We have tracked over 132 funding programs and $17,679,999 allocated for Drug Abuse Research and Prevention.
| Recent Funding Opportunity |
|---|
| Neuroscience Research on Drug Abuse (R21) (apply for PA 17 112) Funding Number: PA 17 112 Agency: National Institutes of Health Funding Amount: $200,000 |
| The Application of Big Data Analytics to Drug Abuse Research (R01) (apply for PA 16 119) Funding Number: PA 16 119 Agency: HHS-NIH11 Funding Amount: Case Dependent |
| Neuroscience Research on Drug Abuse (R01) (apply for PA 13 338) Funding Number: PA 13 338 Agency: National Institutes of Health Funding Amount: Case Dependent |
| Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) (apply for PAR 18 064) Funding Number: PAR 18 064 Agency: National Institutes of Health Funding Amount: $200,000 |
| Role of Astrocytes and Astrocytic Networks in Drug Abuse (R01) (apply for PA 16 144) Funding Number: PA 16 144 Agency: HHS-NIH11 Funding Amount: Case Dependent |
| Prescription Drug Abuse (R21 Clinical Trial Optional) (apply for PA 18 076) Funding Number: PA 18 076 Agency: National Institutes of Health Funding Amount: $200,000 |
| Health Services Research on Practice Improvement Utilizing Community Treatment Programs within the National Drug Abuse Clinical Trials Network (CTN) (R21) (apply for PA 06 496) Funding Number: PA 06 496 Agency: National Institutes of Health Funding Amount: $200,000 |
| The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Optional) (apply for RFA DA 19 008) Funding Number: RFA DA 19 008 Agency: Department of Health and Human Services, National Institutes of Health Funding Amount: $500,000 |
| Epidemiology of Drug Abuse (R21) (apply for PA 15 001) Funding Number: PA 15 001 Agency: National Institutes of Health Funding Amount: $275,000 |
| Epidemiology of Drug Abuse (R21) (apply for PA 11 231) Funding Number: PA 11 231 Agency: National Institutes of Health Funding Amount: $200,000 |
| Neuroscience Research on Drug Abuse (R21) (apply for PA 10 269) Funding Number: PA 10 269 Agency: National Institutes of Health Funding Amount: $200,000 |
| HIV/AIDS High Priority Drug Abuse Research (R01 Clinical Trial Optional) (apply for PAS 18 063) Funding Number: PAS 18 063 Agency: National Institutes of Health Funding Amount: Case Dependent |
| Drug Abuse Aspects of HIV/AIDS (R21) (apply for PA 07 309) Funding Number: PA 07 309 Agency: National Institutes of Health Funding Amount: Case Dependent |
| International Research Collaboration on Drug Abuse and Addiction Research (R01 Clinical Trial Optional) (apply for PA 18 773) Funding Number: PA 18 773 Agency: National Institutes of Health Funding Amount: Case Dependent |
| Cognitive Remediation Approaches to Improve Drug Abuse Treatment Outcomes (R01) (apply for RFA DA 10 006) Funding Number: RFA DA 10 006 Agency: National Institutes of Health Funding Amount: Case Dependent |
| Drug Abuse Prevention Intervention Research (R21) (apply for PA 11 312) Funding Number: PA 11 312 Agency: National Institutes of Health Funding Amount: $200,000 |
| Drug Abuse Dissertation Research Epidemiology, Prevention, Treatment, Services, and/or Women and Sex/Gender Differences (R36) (apply for PAR 10 020) Funding Number: PAR 10 020 Agency: National Institutes of Health Funding Amount: $50,000 |
| Cognitive Remediation Approaches to Improve Drug Abuse Treatment Outcomes (R21) (apply for RFA DA 10 007) Funding Number: RFA DA 10 007 Agency: National Institutes of Health Funding Amount: $200,000 |
| Drug Abuse Aspects of HIV/AIDS (R03) (apply for PA 07 308) Funding Number: PA 07 308 Agency: National Institutes of Health Funding Amount: Case Dependent |
| Neuroscience Research on Drug Abuse (R01) (apply for PA 17 111) Funding Number: PA 17 111 Agency: National Institutes of Health Funding Amount: Case Dependent |
| Deep Sequencing and Analysis of Pharmacogenomic Regions Discovery and Analysis of Genetic Variants Contributing to Drug Abuse and Addiction (R01) (apply for RFA DA 10 019) Funding Number: RFA DA 10 019 Agency: National Institutes of Health Funding Amount: $250,000 |
| Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) (apply for PAR 22 027) Funding Number: PAR 22 027 Agency: National Institutes of Health Funding Amount: $275,000 |
| Drug Abuse Prevention Intervention Research (R01) (apply for PA 08 217) Funding Number: PA 08 217 Agency: National Institutes of Health Funding Amount: Case Dependent |
| Accelerating the Pace of Drug Abuse Research Using Existing Epidemiology, Prevention, and Treatment Research Data (R01) (apply for PAR 10 018) Funding Number: PAR 10 018 Agency: National Institutes of Health Funding Amount: $250,000 |
| Interactions between Physical Activity and Drug Abuse (R01) (apply for RFA DA 09 013) Funding Number: RFA DA 09 013 Agency: National Institutes of Health Funding Amount: Case Dependent |
Inside USGrants.org Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads